ВЛИЯНИЕ ПОЛИМОРФИЗМА ГЕНА CD14 НА ТЕЧЕНИЕ И ИСХОД НОЗОКОМИАЛЬНОЙ ПНЕВМОНИИ
https://doi.org/10.15789/1563-0625-2010-1-2-95-102
Аннотация
Об авторах
Е. А. БайгозинаРоссия
В. И. Совалкин
Россия
Список литературы
1. Симбирцев А.С., Громова А.Ю. Функциональный полиморфизм генов регуляторных молекул воспаления// Цитокины и воспаление. -2005. -Т. 4, № 1. -С. 3-10.
2. Agnese D.M., Calvano J.E., Hahm S.J. Human toll-like receptor 4 mutation but not CD14 polymorphisms are associated with an increased risk of gram-negative infections// J. Infect. Dis. -2002. -Vol. 186. -P. 1522-1525.
3. Antal-Szalmas P., van Strijp J.A.G., Weersink A.J.L., Verhoef J., van Kessel K.P.M. Quantitation of surface CD14 on human monocytes and neutrophils// J. Leukoc. Biol. -1997. - Vol. 62. -P. 721-728.
4. Arcaroli J., Fessler M.B., Abraham E. Genetic polymorphisms and sepsis// Shock. -2005. -Vol. 24, N 4. -P. 300-312.
5. Von Aulock S., Rupp J., Gueinzius K., Maass M., Hermann C. Critical investigation of the CD14 promoter polymorphism: lack of a role for in vitro cytokine response and membrane CD14 expression// Clinical and Diagnostic Laboratory Immunology. -2005. -Vol. 12, N 10. -P. 1254-1256.
6. Barber R.C., Chang L.Y.E., Arnoldo B.D., Purdue G.F., Hunt J.L., Horton J.W., Aragaki C.C. Innate immunity SNPs are associated with risk for severe sepsis after burn injury// Clinical Medicine. -2006. -Vol. 4, N 4. -P. 250-255.
7. Ebong S.J., Goyert S.M., Nemzek J.A., Kim J., Bolgos G.L., Remick D. Critical role of CD14 for production of proinflammatory cytokines and cytokine inhibitors during sepsis with failure to alter morbidity or mortality// Infection and Immunity. -2001. -P. 2099-2106.
8. Eng H.L., Chen C.H., Kuo C.C., Wu J.S., Wang C.H., Lin T.M. Association of CD14 promoter gene polymorphism and Chlamydia pneumoniae infectio// J. Infect. Dis. -2003. -Vol. 188. -P. 90-97.
9. Eng H.L., Wang C.H., Chen C.H., Chou M.H., Cheng C.T., Lin T.M. A CD14 promoter polymorphism is associated with CD14 expression and Chlamydia -stimulated TNF alpha production// Genes Immun. -2004. -Vol. 5. -P. 426-430.
10. Ferrero E., Jiao D., Tsuberi B.Z., Tesio L., Wei Rong G., Haziot A. Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide// Proc. Natl. Acad. Sci. USA. -1993. -Vol. 90. -P. 2380-2384.
11. Gibot S., Cariou A., Drouet L., Rossignol M., Ripoll L. Association between a genomic polymorphism within the CD 14 locus and septic shock susceptibility and mortality rate// Crit. Care Med. -2002. -Vol. 30. -P. 969-973.
12. Haziot A., Ferrero E., Kntgen F., Hijiya N., Yamamoto S., Silver J., Stewart C.L., Goyert S.M. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria on CD14-deficient mice// Immunity. -1996. - Vol. 4. -P. 407-414.
13. Haziot A., Hijiya N., Schultz K., Zhang F., Gangloff S.C., Goyert S.M. CD14 plays no major role in shock induced by Staphylococcus aureus but down-regulates TNF-alpha production// J. Immunol. -1999. -Vol. 162. -P. 4801-4805.
14. Heesen M., Blomeke B., Schluter B., Heussen N., Rossaint R., Kunz D. Lack of association between the -260 C→T promoter polymorphism of the endotoxin receptor CD14 gene and the CD14 density of unstimulated human monocytes and soluble CD14 plasma levels// Intens. Care Med. -2001. -Vol. 27. -P. 1770-1775.
15. Heesen M., Bloemeke B., Schade U., Obertacke U., Majetschak M. The -260 C→T promoter polymorphism of the lipopolysaccharide receptor CD14 and severe sepsis in trauma patients// Intensive Care Med. -2002. -Vol. 28. -P. 1161-1163.
16. Hoshido K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: toll-like receptor 4 (TLR4) -deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product// J. Immunol. -1999. -Vol. 162. -P. 3749-3752.
17. Hubacek J.A., Pit’ha J., Skodova Z., Stanek V., Poledne R. C(-260)→T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction// Circulation. -1999. -Vol. 99. -P. 3218-3220.
18. Hubacek J.A., Stuber F., Frohlich D. The common functional C(-159)→T polymorphism wihin the promoter region of the lipopolysaccharide receptor CD14 is not associated with sepsis development or mortality// Genes. Immun. -2000. -Vol. 1. -P. 405-407.
19. Ito D., Murata M., Tanahashi N. Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease// Stroke. -2000. -Vol. 31. -P. 2661-2664.
20. Kitchens R.L., Thompson P.A., Viriyakosol S., O’Keefe G.E., Munford R.S. Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins// J. Clin. Invest. -2001. -Vol. 108. -P. 485-493.
21. Kondo T., Ohno M., Shimokata K., Iino S., Inden Y., Murohara T., Hirai M. CD14 promoter polymorphism is associated with acute myocardial infarction resulting from insignificant coronary artery stenosis// Heart. -2003. -Vol. 89. -P. 931-932.
22. Van der Linden M.W., Huizinga T.W., Stoeken D.J., Sturk A., Westendorp R.G. Determination of tumor necrosis factor-alpha and interleukin-10 production in a whole blood stimulation system: assessment of laboratory error and individual variation// J. Immunol. Methods. -1998. -Vol. 218. -P. 63-71.
23. Netea M.G., Galama J.M.D., Kullberg B.J., Stalenhoef A.F.H., Dinarello C.A., Van der Meer J.W.M. Non -LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways// Eur. J. Immunol. -2002. -Vol. 32. -P. 1188-1195.
24. Poltorak A., Ricciardi-Castagnoli P., Citterio S., Beutler B. Physical contact between lipopolysaccharide and toll-like receptor 4 revealed by genetic complementation// Proc. Natl. Acad. Sci. USA. -2000. -Vol. 97. -P. 2163-2167.
25. Da Silva Correia J., Soldau K., Christen U., Tobias P.S., Ulevitch R.J. Lipopolysaccharide is in close proximity to each of the protein in its membrane receptor complex: transfer from CD14 to TLR4 and MD2// J. Biol. Chem. -2001. -Vol. 276. - P. 21129-21135.
26. Temple S.E.L., Cheong K.Y., Almeida C.M., Price P., Waterer G.W. Polymorphisms in lymphotoxin alpha and CD14 genes influence TNFα production induced by gram-positive and gram-negative bacteria// Genes and Immunity. -2003. -Vol. 4. -P. 283-288.
27. Le Van T.D, Bloom J.W., Bailey T.J. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity// J. Immunol. -2001. -Vol. 167. -P. 5838-5844.
Рецензия
Для цитирования:
Байгозина Е.А., Совалкин В.И. ВЛИЯНИЕ ПОЛИМОРФИЗМА ГЕНА CD14 НА ТЕЧЕНИЕ И ИСХОД НОЗОКОМИАЛЬНОЙ ПНЕВМОНИИ. Медицинская иммунология. 2010;12(1-2):95-102. https://doi.org/10.15789/1563-0625-2010-1-2-95-102
For citation:
Baygozina E.A., Sovalkin V.I. INFLUENCE OF CD14 GENE POLYMORHISM ON CLINIC AL COURSE AND OUTCOME OF NOSOCOMIAL PNEUMONIA. Medical Immunology (Russia). 2010;12(1-2):95-102. (In Russ.) https://doi.org/10.15789/1563-0625-2010-1-2-95-102